Shanghai WuXi Biomedical Co. was founded on 07/04/2017. The company's business scope includes: pharmaceutical production, wholesale, import and export of goods of the same kind as the above products, foodstuffs (except grain), and provision of related supporting services.
Biotechnology, medical science and technology in the field of technology development, technical consulting, technical services, technology transfer (human stem cells, gene diagnosis and treatment technology development and application except) (does not involve the state trade management commodities, involving quotas, licenses management commodities, in accordance with the relevant provisions of the State for the application; involves the administrative licensing, with a license to operate).
Pharmaceutical is a multidisciplinary theory and advanced technology of the mutual combination of scientific and modern mode, research, development and production of pharmaceutical products. In addition to biopharmaceuticals, chemical and traditional Chinese medicines also occupy a certain proportion in the pharmaceutical industry.
Shanghai Yeming Bio-pharmaceuticals has been able to penetrate the world market because it has preserved its ancestral secret recipe and integrated the research and development of modern pharmaceutical science. Moreover, Shanghai Yeming Bio-medicine medicinal herbs are found all over the world, from the south of the Yangtze River Basin in China to North Africa, the Mediterranean Sea, West Asia and Central Asia abroad.
Yaoming Bio's research direction:
Yaoming Bio researches biomedical engineering, comprehensively applies the principles and methods of life sciences and engineering sciences, and recognizes the human body's structure, function, and other life phenomena from the engineering point of view at the molecular, cellular, tissue, organ, and even the whole human body system at multiple levels, and researches the methods used to The general term for artificial materials, products, devices and system technologies for disease prevention, disease treatment, human function assistance and health care.
The biomedical engineering industry includes: biomedical material products, (bio)artificial organs, medical imaging and diagnostic equipment, medical electronic instruments and monitoring devices, modern medical treatment equipment, medical information technology, rehabilitation engineering technology and devices, and tissue engineering.
The third-party platform is a neutral service organization independent of the buyer and seller, providing the buyer and seller with a digital platform for the various services required for the transaction, i.e., providing pharmaceutical information dissemination, online purchasing, online trading, online payment, drug tracking, with the ground warehousing and logistics and other pharmaceutical circulation services, and realizing the complete pharmaceutical e-commerce service with a high degree of synergy of information flow, capital flow and logistics. It is a complete pharmaceutical e-commerce service that realizes a high degree of synergy in information flow, capital flow and logistics, and is an open, fair and impartial online pharmaceutical trading market.
Reference: Baidu Encyclopedia-Shanghai WuXi Biomedical Co.